Global Sitagliptin Metformin Extended Release Tablets Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Page: 105

Published Date: 09 Sep 2024

Category: Pharma & Healthcare

PDF Download

Get FREE Sample

Customize Request

Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags

Description

Sitagliptin Metformin Extended Release Tablets is a combination drug used to treat type 2 diabetes. Through the synergistic effect of sitagliptin and metformin, it helps patients better control blood sugar levels. This drug is suitable for patients who have poor blood sugar control through diet and exercise. It can lower blood sugar and improve insulin resistance through different mechanisms.

According to our (Global Info Research) latest study, the global Sitagliptin Metformin Extended Release Tablets market size was valued at US$ million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of %during review period.

This report is a detailed and comprehensive analysis for global Sitagliptin Metformin Extended Release Tablets market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2024, are provided.

Key Features:
Global Sitagliptin Metformin Extended Release Tablets market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Sitagliptin Metformin Extended Release Tablets market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Sitagliptin Metformin Extended Release Tablets market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2019-2030
Global Sitagliptin Metformin Extended Release Tablets market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2019-2024
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Sitagliptin Metformin Extended Release Tablets
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Sitagliptin Metformin Extended Release Tablets market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Jiangsu Anbisheng Pharmaceutical Co., Ltd., Jiangsu Xuantai Pharmaceutical Co., Ltd., Chia Tai Tianqing Pharmaceutical Group, Merck & Co., Inc., Abbott, Sandoz Pty Ltd, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Market Segmentation
Sitagliptin Metformin Extended Release Tablets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
    Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
    Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg

Market segment by Application
    Hospital
    Clinic
    Other

Major players covered
    Jiangsu Anbisheng Pharmaceutical Co., Ltd.
    Jiangsu Xuantai Pharmaceutical Co., Ltd.
    Chia Tai Tianqing Pharmaceutical Group
    Merck & Co., Inc.
    Abbott
    Sandoz Pty Ltd

Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Sitagliptin Metformin Extended Release Tablets product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Sitagliptin Metformin Extended Release Tablets, with price, sales quantity, revenue, and global market share of Sitagliptin Metformin Extended Release Tablets from 2019 to 2024.
Chapter 3, the Sitagliptin Metformin Extended Release Tablets competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Sitagliptin Metformin Extended Release Tablets breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2019 to 2024.and Sitagliptin Metformin Extended Release Tablets market forecast, by regions, by Type, and by Application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Sitagliptin Metformin Extended Release Tablets.
Chapter 14 and 15, to describe Sitagliptin Metformin Extended Release Tablets sales channel, distributors, customers, research findings and conclusion.

Table of Contents

1 Market Overview
    1.1 Product Overview and Scope
    1.2 Market Estimation Caveats and Base Year
    1.3 Market Analysis by Type
        1.3.1 Overview: Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Type: 2019 Versus 2023 Versus 2030
        1.3.2 Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg
        1.3.3 Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg
    1.4 Market Analysis by Application
        1.4.1 Overview: Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Application: 2019 Versus 2023 Versus 2030
        1.4.2 Hospital
        1.4.3 Clinic
        1.4.4 Other
    1.5 Global Sitagliptin Metformin Extended Release Tablets Market Size & Forecast
        1.5.1 Global Sitagliptin Metformin Extended Release Tablets Consumption Value (2019 & 2023 & 2030)
        1.5.2 Global Sitagliptin Metformin Extended Release Tablets Sales Quantity (2019-2030)
        1.5.3 Global Sitagliptin Metformin Extended Release Tablets Average Price (2019-2030)

2 Manufacturers Profiles
    2.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd.
        2.1.1 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Details
        2.1.2 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Major Business
        2.1.3 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product and Services
        2.1.4 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.1.5 Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
    2.2 Jiangsu Xuantai Pharmaceutical Co., Ltd.
        2.2.1 Jiangsu Xuantai Pharmaceutical Co., Ltd. Details
        2.2.2 Jiangsu Xuantai Pharmaceutical Co., Ltd. Major Business
        2.2.3 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product and Services
        2.2.4 Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.2.5 Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates
    2.3 Chia Tai Tianqing Pharmaceutical Group
        2.3.1 Chia Tai Tianqing Pharmaceutical Group Details
        2.3.2 Chia Tai Tianqing Pharmaceutical Group Major Business
        2.3.3 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product and Services
        2.3.4 Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.3.5 Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
    2.4 Merck & Co., Inc.
        2.4.1 Merck & Co., Inc. Details
        2.4.2 Merck & Co., Inc. Major Business
        2.4.3 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product and Services
        2.4.4 Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.4.5 Merck & Co., Inc. Recent Developments/Updates
    2.5 Abbott
        2.5.1 Abbott Details
        2.5.2 Abbott Major Business
        2.5.3 Abbott Sitagliptin Metformin Extended Release Tablets Product and Services
        2.5.4 Abbott Sitagliptin Metformin Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.5.5 Abbott Recent Developments/Updates
    2.6 Sandoz Pty Ltd
        2.6.1 Sandoz Pty Ltd Details
        2.6.2 Sandoz Pty Ltd Major Business
        2.6.3 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product and Services
        2.6.4 Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
        2.6.5 Sandoz Pty Ltd Recent Developments/Updates

3 Competitive Environment: Sitagliptin Metformin Extended Release Tablets by Manufacturer
    3.1 Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Manufacturer (2019-2024)
    3.2 Global Sitagliptin Metformin Extended Release Tablets Revenue by Manufacturer (2019-2024)
    3.3 Global Sitagliptin Metformin Extended Release Tablets Average Price by Manufacturer (2019-2024)
    3.4 Market Share Analysis (2023)
        3.4.1 Producer Shipments of Sitagliptin Metformin Extended Release Tablets by Manufacturer Revenue ($MM) and Market Share (%): 2023
        3.4.2 Top 3 Sitagliptin Metformin Extended Release Tablets Manufacturer Market Share in 2023
        3.4.3 Top 6 Sitagliptin Metformin Extended Release Tablets Manufacturer Market Share in 2023
    3.5 Sitagliptin Metformin Extended Release Tablets Market: Overall Company Footprint Analysis
        3.5.1 Sitagliptin Metformin Extended Release Tablets Market: Region Footprint
        3.5.2 Sitagliptin Metformin Extended Release Tablets Market: Company Product Type Footprint
        3.5.3 Sitagliptin Metformin Extended Release Tablets Market: Company Product Application Footprint
    3.6 New Market Entrants and Barriers to Market Entry
    3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
    4.1 Global Sitagliptin Metformin Extended Release Tablets Market Size by Region
        4.1.1 Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Region (2019-2030)
        4.1.2 Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Region (2019-2030)
        4.1.3 Global Sitagliptin Metformin Extended Release Tablets Average Price by Region (2019-2030)
    4.2 North America Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030)
    4.3 Europe Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030)
    4.4 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030)
    4.5 South America Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030)
    4.6 Middle East & Africa Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030)

5 Market Segment by Type
    5.1 Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2030)
    5.2 Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Type (2019-2030)
    5.3 Global Sitagliptin Metformin Extended Release Tablets Average Price by Type (2019-2030)

6 Market Segment by Application
    6.1 Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2030)
    6.2 Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Application (2019-2030)
    6.3 Global Sitagliptin Metformin Extended Release Tablets Average Price by Application (2019-2030)

7 North America
    7.1 North America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2030)
    7.2 North America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2030)
    7.3 North America Sitagliptin Metformin Extended Release Tablets Market Size by Country
        7.3.1 North America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2019-2030)
        7.3.2 North America Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2019-2030)
        7.3.3 United States Market Size and Forecast (2019-2030)
        7.3.4 Canada Market Size and Forecast (2019-2030)
        7.3.5 Mexico Market Size and Forecast (2019-2030)

8 Europe
    8.1 Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2030)
    8.2 Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2030)
    8.3 Europe Sitagliptin Metformin Extended Release Tablets Market Size by Country
        8.3.1 Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2019-2030)
        8.3.2 Europe Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2019-2030)
        8.3.3 Germany Market Size and Forecast (2019-2030)
        8.3.4 France Market Size and Forecast (2019-2030)
        8.3.5 United Kingdom Market Size and Forecast (2019-2030)
        8.3.6 Russia Market Size and Forecast (2019-2030)
        8.3.7 Italy Market Size and Forecast (2019-2030)

9 Asia-Pacific
    9.1 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2030)
    9.2 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2030)
    9.3 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Market Size by Region
        9.3.1 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity by Region (2019-2030)
        9.3.2 Asia-Pacific Sitagliptin Metformin Extended Release Tablets Consumption Value by Region (2019-2030)
        9.3.3 China Market Size and Forecast (2019-2030)
        9.3.4 Japan Market Size and Forecast (2019-2030)
        9.3.5 South Korea Market Size and Forecast (2019-2030)
        9.3.6 India Market Size and Forecast (2019-2030)
        9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
        9.3.8 Australia Market Size and Forecast (2019-2030)

10 South America
    10.1 South America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2030)
    10.2 South America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2030)
    10.3 South America Sitagliptin Metformin Extended Release Tablets Market Size by Country
        10.3.1 South America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2019-2030)
        10.3.2 South America Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2019-2030)
        10.3.3 Brazil Market Size and Forecast (2019-2030)
        10.3.4 Argentina Market Size and Forecast (2019-2030)

11 Middle East & Africa
    11.1 Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2030)
    11.2 Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2030)
    11.3 Middle East & Africa Sitagliptin Metformin Extended Release Tablets Market Size by Country
        11.3.1 Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2019-2030)
        11.3.2 Middle East & Africa Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2019-2030)
        11.3.3 Turkey Market Size and Forecast (2019-2030)
        11.3.4 Egypt Market Size and Forecast (2019-2030)
        11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
        11.3.6 South Africa Market Size and Forecast (2019-2030)

12 Market Dynamics
    12.1 Sitagliptin Metformin Extended Release Tablets Market Drivers
    12.2 Sitagliptin Metformin Extended Release Tablets Market Restraints
    12.3 Sitagliptin Metformin Extended Release Tablets Trends Analysis
    12.4 Porters Five Forces Analysis
        12.4.1 Threat of New Entrants
        12.4.2 Bargaining Power of Suppliers
        12.4.3 Bargaining Power of Buyers
        12.4.4 Threat of Substitutes
        12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain
    13.1 Raw Material of Sitagliptin Metformin Extended Release Tablets and Key Manufacturers
    13.2 Manufacturing Costs Percentage of Sitagliptin Metformin Extended Release Tablets
    13.3 Sitagliptin Metformin Extended Release Tablets Production Process
    13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel
    14.1 Sales Channel
        14.1.1 Direct to End-User
        14.1.2 Distributors
    14.2 Sitagliptin Metformin Extended Release Tablets Typical Distributors
    14.3 Sitagliptin Metformin Extended Release Tablets Typical Customers

15 Research Findings and Conclusion

16 Appendix
    16.1 Methodology
    16.2 Research Process and Data Source
    16.3 Disclaimer

Table of Figures

List of Tables
 Table 1. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
 Table 2. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Table 3. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 4. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Major Business
 Table 5. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 6. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 7. Jiangsu Anbisheng Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 8. Jiangsu Xuantai Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
 Table 9. Jiangsu Xuantai Pharmaceutical Co., Ltd. Major Business
 Table 10. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 11. Jiangsu Xuantai Pharmaceutical Co., Ltd. Sitagliptin Metformin Extended Release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 12. Jiangsu Xuantai Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 13. Chia Tai Tianqing Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
 Table 14. Chia Tai Tianqing Pharmaceutical Group Major Business
 Table 15. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 16. Chia Tai Tianqing Pharmaceutical Group Sitagliptin Metformin Extended Release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 17. Chia Tai Tianqing Pharmaceutical Group Recent Developments/Updates
 Table 18. Merck & Co., Inc. Basic Information, Manufacturing Base and Competitors
 Table 19. Merck & Co., Inc. Major Business
 Table 20. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 21. Merck & Co., Inc. Sitagliptin Metformin Extended Release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 22. Merck & Co., Inc. Recent Developments/Updates
 Table 23. Abbott Basic Information, Manufacturing Base and Competitors
 Table 24. Abbott Major Business
 Table 25. Abbott Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 26. Abbott Sitagliptin Metformin Extended Release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 27. Abbott Recent Developments/Updates
 Table 28. Sandoz Pty Ltd Basic Information, Manufacturing Base and Competitors
 Table 29. Sandoz Pty Ltd Major Business
 Table 30. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Product and Services
 Table 31. Sandoz Pty Ltd Sitagliptin Metformin Extended Release Tablets Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
 Table 32. Sandoz Pty Ltd Recent Developments/Updates
 Table 33. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Manufacturer (2019-2024) & (K Units)
 Table 34. Global Sitagliptin Metformin Extended Release Tablets Revenue by Manufacturer (2019-2024) & (USD Million)
 Table 35. Global Sitagliptin Metformin Extended Release Tablets Average Price by Manufacturer (2019-2024) & (US$/Unit)
 Table 36. Market Position of Manufacturers in Sitagliptin Metformin Extended Release Tablets, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
 Table 37. Head Office and Sitagliptin Metformin Extended Release Tablets Production Site of Key Manufacturer
 Table 38. Sitagliptin Metformin Extended Release Tablets Market: Company Product Type Footprint
 Table 39. Sitagliptin Metformin Extended Release Tablets Market: Company Product Application Footprint
 Table 40. Sitagliptin Metformin Extended Release Tablets New Market Entrants and Barriers to Market Entry
 Table 41. Sitagliptin Metformin Extended Release Tablets Mergers, Acquisition, Agreements, and Collaborations
 Table 42. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Region (2019-2023-2030) & (USD Million) & CAGR
 Table 43. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Region (2019-2024) & (K Units)
 Table 44. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Region (2025-2030) & (K Units)
 Table 45. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Region (2019-2024) & (USD Million)
 Table 46. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Region (2025-2030) & (USD Million)
 Table 47. Global Sitagliptin Metformin Extended Release Tablets Average Price by Region (2019-2024) & (US$/Unit)
 Table 48. Global Sitagliptin Metformin Extended Release Tablets Average Price by Region (2025-2030) & (US$/Unit)
 Table 49. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 50. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 51. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Type (2019-2024) & (USD Million)
 Table 52. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Type (2025-2030) & (USD Million)
 Table 53. Global Sitagliptin Metformin Extended Release Tablets Average Price by Type (2019-2024) & (US$/Unit)
 Table 54. Global Sitagliptin Metformin Extended Release Tablets Average Price by Type (2025-2030) & (US$/Unit)
 Table 55. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 56. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 57. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Application (2019-2024) & (USD Million)
 Table 58. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Application (2025-2030) & (USD Million)
 Table 59. Global Sitagliptin Metformin Extended Release Tablets Average Price by Application (2019-2024) & (US$/Unit)
 Table 60. Global Sitagliptin Metformin Extended Release Tablets Average Price by Application (2025-2030) & (US$/Unit)
 Table 61. North America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 62. North America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 63. North America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 64. North America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 65. North America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2019-2024) & (K Units)
 Table 66. North America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2025-2030) & (K Units)
 Table 67. North America Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2019-2024) & (USD Million)
 Table 68. North America Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2025-2030) & (USD Million)
 Table 69. Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 70. Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 71. Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 72. Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 73. Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2019-2024) & (K Units)
 Table 74. Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2025-2030) & (K Units)
 Table 75. Europe Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2019-2024) & (USD Million)
 Table 76. Europe Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2025-2030) & (USD Million)
 Table 77. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 78. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 79. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 80. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 81. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity by Region (2019-2024) & (K Units)
 Table 82. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity by Region (2025-2030) & (K Units)
 Table 83. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Consumption Value by Region (2019-2024) & (USD Million)
 Table 84. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Consumption Value by Region (2025-2030) & (USD Million)
 Table 85. South America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 86. South America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 87. South America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 88. South America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 89. South America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2019-2024) & (K Units)
 Table 90. South America Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2025-2030) & (K Units)
 Table 91. South America Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2019-2024) & (USD Million)
 Table 92. South America Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2025-2030) & (USD Million)
 Table 93. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2019-2024) & (K Units)
 Table 94. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity by Type (2025-2030) & (K Units)
 Table 95. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2019-2024) & (K Units)
 Table 96. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity by Application (2025-2030) & (K Units)
 Table 97. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2019-2024) & (K Units)
 Table 98. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity by Country (2025-2030) & (K Units)
 Table 99. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2019-2024) & (USD Million)
 Table 100. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Consumption Value by Country (2025-2030) & (USD Million)
 Table 101. Sitagliptin Metformin Extended Release Tablets Raw Material
 Table 102. Key Manufacturers of Sitagliptin Metformin Extended Release Tablets Raw Materials
 Table 103. Sitagliptin Metformin Extended Release Tablets Typical Distributors
 Table 104. Sitagliptin Metformin Extended Release Tablets Typical Customers


List of Figures
 Figure 1. Sitagliptin Metformin Extended Release Tablets Picture
 Figure 2. Global Sitagliptin Metformin Extended Release Tablets Revenue by Type, (USD Million), 2019 & 2023 & 2030
 Figure 3. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Type in 2023
 Figure 4. Sitagliptin Phosphate 50mg (Calculated as C₁₆H₁₅F₆N₅O) and Metformin Hydrochloride 500mg Examples
 Figure 5. Sitagliptin Phosphate 100mg (Calculated as C16H15F6N5O) and Metformin Hydrochloride 1000mg Examples
 Figure 6. Global Sitagliptin Metformin Extended Release Tablets Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
 Figure 7. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application in 2023
 Figure 8. Hospital Examples
 Figure 9. Clinic Examples
 Figure 10. Other Examples
 Figure 11. Global Sitagliptin Metformin Extended Release Tablets Consumption Value, (USD Million): 2019 & 2023 & 2030
 Figure 12. Global Sitagliptin Metformin Extended Release Tablets Consumption Value and Forecast (2019-2030) & (USD Million)
 Figure 13. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity (2019-2030) & (K Units)
 Figure 14. Global Sitagliptin Metformin Extended Release Tablets Price (2019-2030) & (US$/Unit)
 Figure 15. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Manufacturer in 2023
 Figure 16. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Manufacturer in 2023
 Figure 17. Producer Shipments of Sitagliptin Metformin Extended Release Tablets by Manufacturer Sales ($MM) and Market Share (%): 2023
 Figure 18. Top 3 Sitagliptin Metformin Extended Release Tablets Manufacturer (Revenue) Market Share in 2023
 Figure 19. Top 6 Sitagliptin Metformin Extended Release Tablets Manufacturer (Revenue) Market Share in 2023
 Figure 20. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Region (2019-2030)
 Figure 21. Global Sitagliptin Metformin Extended Release Tablets Consumption Value Market Share by Region (2019-2030)
 Figure 22. North America Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 23. Europe Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 24. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 25. South America Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 26. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 27. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 28. Global Sitagliptin Metformin Extended Release Tablets Consumption Value Market Share by Type (2019-2030)
 Figure 29. Global Sitagliptin Metformin Extended Release Tablets Average Price by Type (2019-2030) & (US$/Unit)
 Figure 30. Global Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 31. Global Sitagliptin Metformin Extended Release Tablets Revenue Market Share by Application (2019-2030)
 Figure 32. Global Sitagliptin Metformin Extended Release Tablets Average Price by Application (2019-2030) & (US$/Unit)
 Figure 33. North America Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 34. North America Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 35. North America Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Country (2019-2030)
 Figure 36. North America Sitagliptin Metformin Extended Release Tablets Consumption Value Market Share by Country (2019-2030)
 Figure 37. United States Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 38. Canada Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 39. Mexico Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 40. Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 41. Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 42. Europe Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Country (2019-2030)
 Figure 43. Europe Sitagliptin Metformin Extended Release Tablets Consumption Value Market Share by Country (2019-2030)
 Figure 44. Germany Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 45. France Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 46. United Kingdom Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 47. Russia Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 48. Italy Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 49. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 50. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 51. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Region (2019-2030)
 Figure 52. Asia-Pacific Sitagliptin Metformin Extended Release Tablets Consumption Value Market Share by Region (2019-2030)
 Figure 53. China Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 54. Japan Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 55. South Korea Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 56. India Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 57. Southeast Asia Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 58. Australia Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 59. South America Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 60. South America Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 61. South America Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Country (2019-2030)
 Figure 62. South America Sitagliptin Metformin Extended Release Tablets Consumption Value Market Share by Country (2019-2030)
 Figure 63. Brazil Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 64. Argentina Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 65. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Type (2019-2030)
 Figure 66. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Application (2019-2030)
 Figure 67. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Sales Quantity Market Share by Country (2019-2030)
 Figure 68. Middle East & Africa Sitagliptin Metformin Extended Release Tablets Consumption Value Market Share by Country (2019-2030)
 Figure 69. Turkey Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 70. Egypt Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 71. Saudi Arabia Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 72. South Africa Sitagliptin Metformin Extended Release Tablets Consumption Value (2019-2030) & (USD Million)
 Figure 73. Sitagliptin Metformin Extended Release Tablets Market Drivers
 Figure 74. Sitagliptin Metformin Extended Release Tablets Market Restraints
 Figure 75. Sitagliptin Metformin Extended Release Tablets Market Trends
 Figure 76. Porters Five Forces Analysis
 Figure 77. Manufacturing Cost Structure Analysis of Sitagliptin Metformin Extended Release Tablets in 2023
 Figure 78. Manufacturing Process Analysis of Sitagliptin Metformin Extended Release Tablets
 Figure 79. Sitagliptin Metformin Extended Release Tablets Industrial Chain
 Figure 80. Sales Channel: Direct to End-User vs Distributors
 Figure 81. Direct Channel Pros & Cons
 Figure 82. Indirect Channel Pros & Cons
 Figure 83. Methodology
 Figure 84. Research Process and Data Source

Research Methodology

Client Requirements

Review and analyze client requirements

Discussion of all the project requirements and queries

Flexibility Check

Project Feasibility Analysis

Finalizing tentative research programme

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

Determination of key drivers, restraints, challenge, and opportunity

Identifies market needs and trends

Market Size Estimation & Forecast

Estimation of historical data based on secondary and primary data

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

Consideration of geography, region-specific product/service demand for region segments

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

Data Source

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

Collection of data

Cumulating and collating the essential qualitative and quantitative data

Generation of report in client requested format by research analysts

Reviews by expert analysts

Final quality check

Clarifying queries

Receiving feedback

Ensuring satisfaction

01 Identification of data

This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
02 Evaluation of Market Dynamic

This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
03 Collection of Data

This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
04 Collaboration of Data

This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis

This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

Companies Mentioned

Jiangsu Anbisheng Pharmaceutical Co., Ltd.
Jiangsu Xuantai Pharmaceutical Co., Ltd.
Chia Tai Tianqing Pharmaceutical Group
Merck & Co., Inc.
Abbott
Sandoz Pty Ltd

Related Reports

Global Sitagliptin Metformin Extended Release Tablets Supply, Demand and Key Producers, 2024-2030

Global Sitagliptin Metformin Extended Release Tablets Supply, Demand and Key Producers, 2024-2030

date 09 Sep 2024

date Pharma & Healthcare

Sitagliptin Metformin Extended Release Tablets is a combination drug used to treat type 2 diabetes. Through the synergistic effect of sitagliptin and metformin, it helps patients better control blood sugar levels. This drug is suitable for patients who have poor blood sugar control through diet and exercise. It can lower blood sugar and improve insulin resistance through different mechanisms.

Product Tags

Sitagliptin Metformin Extended Release Tablets

GABA Supplements

L-carnitine Capsule

Opical Thrombin

Purchase Options

Single User License

USD3480.00

Multi User License

USD5220.00

Corporate Users License

USD6960.00

Add To Cart

Buy Now

Popular Product Keywords

AI
semiconductor
electron
5G
artificial intelligence
Battery
new energy
We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.

Speak to our analyst >>
Our Clients
What We Can Provide?

With better results and higher quality products,Our professional reports can achieve four things:
- Insight into the industry market information
- Analyze market development needs
- Prospects for future development
- Develop industry investment strategy
Digging deeper into global industry information and providing market strategies.

Contact Us >>